Elective cesarean section for women living with HIV: A systematic review of risks and benefits

AIDS

Volumn 31, Issue 11, 2017, Pages 1579-1591

  Kennedy, Caitlin E ^a   Yeh, Ping T ^a   Pandey, Shristi ^a   Betran, Ana P ^b   Narasimhan, Manjulaa ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

cesarean section; elective cesarean section; maternal health; mode of delivery; mother to child transmission; reproductive health; vertical transmission

Indexed keywords

CD4 ANTIGEN;

ANTIRETROVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CESAREAN SECTION; CINAHL; COCHRANE LIBRARY; ELECTIVE SURGERY; EMBASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW INCOME COUNTRY; MATERNAL MORBIDITY; MEDLINE; MEMBRANE RUPTURE; META ANALYSIS; MIDDLE INCOME COUNTRY; OBSERVATIONAL STUDY; PERINATAL CARE; PRACTICE GUIDELINE; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; VAGINAL DELIVERY; VIRUS LOAD; WORLD HEALTH ORGANIZATION; OBSTETRIC DELIVERY; PREGNANCY; PREGNANCY COMPLICATION; PREVENTION AND CONTROL; PROTOCOL COMPLIANCE; REPRODUCTIVE HEALTH; RISK ASSESSMENT; TRANSMISSION; VERTICAL TRANSMISSION;

CESAREAN SECTION; DELIVERY, OBSTETRIC; ELECTIVE SURGICAL PROCEDURES; FEMALE; GUIDELINE ADHERENCE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; OBSERVATIONAL STUDIES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REPRODUCTIVE HEALTH; RISK ASSESSMENT;

EID: 85021774896     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001535     Document Type: Article

References (54)

1. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: a meta-Analysis of 15 prospective cohort studies. N Engl J Med 1999; 340: 977-987.
2. World Health Organization. Guideline on when to start antiretroviral therapy and on preexposure prophylaxis for HIV. Geneva, Switzerland: WHO; September 2015. Available from: http://apps.who.int/iris/bitstream/10665/186275/1/9789241509565-eng.pdf?ua=1. [Accessed 24 April 2017]
3. World Health Organization. WHO statement on caesarean section rates 2015. Geneva, Switzerland: WHO; 2015. Available from: http://apps.who.int/iris/bitstream/10665/161442/1/WHO-RHR-15.02-eng.pdf?ua=1. [Accessed 24 April 2017]
4. Calvert C, Ronsmans C. HIV and the risk of direct obstetric complications: a systematic review and meta-Analysis. PLoS One 2013; 8: e74848.
5. Read JS, Newell MK. Efficacy and safety of cesarean delivery for prevention of mother-To-child transmission of HIV-1. Cochrane Database Syst Rev (4)2005CD005479.
6. Orza L, Welbourn A, Bewley S, Crone ET, Vazquez M. Building a safe house on firm ground: key findings from a global values and preferences survey regarding the sexual and reproductive health and human rights of women living with HIV. London, UK: Salamander Trust; 2015. Available from: http://www. athenanetwork.org/assets/files/General%20-%20publications/BuildingASafeHouseOnFirmGroundFINALreport190115.pdf. [Accessed 24 April 2017]
7. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
8. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-Analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4: 1.
9. The Cochrane Collaboration. Chapter 8.5: The Cochrane Collaboration?s tool for assessing risk of bias. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions 2011. Version 5.1.0 [updated March 2011]. Available from: http://handbook.cochrane.org/chapter-8/8-5-the-cochr ane-collaborations-tool-for-assessing-risk-of-bias.htm. [Accessed 24 April 2017]
10. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-Analyses 1 February 2009. Available from: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. [Accessed 24 April 2017]
11. Comprehensive Meta-Analysis (Version 2) [Computer software]. Englewood, NJ: Biostat; 2014. Available from: https://www. meta-Analysis.com/. [Accessed 24 April 2017]
12. The Cochrane Collaboration. Cochrane handbook for systematic review of interventions. Higgins JPT, Green S, editors. 2011. Version 5.1.0 [updated March 2011]. Available from: http://handbook.cochrane.org. [Accessed 24 April 2017]
13. World Bank. World Bank country classification: country and lending groups. Washington DC: World Bank; 2017. Available from: https://datahelpdesk.worldbank.org/knowledgebase/arti cles/906519-world-bank-country-And-lending-groups. [Accessed 24 April 2017]
14. Bailey A, Newell ML, Peckham C, De Rossi A, Ehrnst A, Grosch-Wörner I, et al. Maternal viral load and vertical transmission of HIV-1 an important factor but not the only one. AIDS 1999; 13: 1377-1385.
15. Bobat R, Coovadia H, Coutsoudis A, Moodley D. Determinants of mother-To-child transmission of human immunodeficiency virus type 1 infection in a cohort from Durban, South Africa. Pediatr Infect Dis J 1996; 15: 604-610.
16. Boer K, England K, Godfried MH, Thorne C. Mode of delivery in HIV-infected pregnant women and prevention of mother-Tochild transmission: changing practices in Western Europe. HIV Med 2010; 11: 368-378.
17. Briand N, Jasseron C, Sibiude J, Azria E, Pollet J, Hammou Y, et al. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010. Am J Obstet Gynecol 2013; 209: 335.e1-335.e12.
18. Cocu M, Thorne C, Matusa R, Tica V, Florea C, Asandi S, et al. Mother-To-child transmission of HIV infection in Romania: results from an education and prevention programme. AIDS Care 2005; 17: 76-84.
19. Duarte G, Read JS, Gonin R, Freimanis L, Ivalo S, Melo VH, et al. Mode of delivery and postpartum morbidity in Latin American and Caribbean countries among women who are infected with human immunodeficiency virus-1: the NICHD International Site Development Initiative (NISDI) Perinatal Study. Am J Obstet Gynecol 2006; 195: 215-229.
20. European Collaborative Study. Mother-To-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 2005; 40: 458-465.
21. European Mode of Delivery Collaboration. Elective caesarean section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999; 353: 1035-1039.
22. Fiore S, Newell ML, Thorne C. Higher rates of postpartum complications in HIV-infected than in uninfected women irrespective of mode of delivery. AIDS 2004; 18: 933-938.
23. Galli L, Puliti D, Chiappini E, Gabiano C, Ferraris G, Mignone F, et al. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-To-child transmission of HIV Type 1?. Clin Infect Dis 2009; 48: 1310-1317.
24. Galli L, Puliti D, Chiappini E, Gabiano C, Tovo PA, Pezzotti P, et al. Lower mother-To-child HIV-1 transmission in boys is independent of type of delivery and antiretroviral prophylaxis: The Italian Reqister for HIV Infection in Children. J Acquir Immune Defic Syndr 2005; 40: 479-485.
25. Grignaffini A, Soncini E, Magnani G, Cavatorta E, Pelicelli A, Verrotti C, et al. Vertical HIV transmission: risk factors and strategies for prevention. Acta Biomedica de l?Ateneo Parmense 2000; 71: 167-178.
26. Grosch-Worner I, Schafer A, Obladen M, Maier RF, Seel K, Feiterna-Sperling C, et al. An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection. AIDS 2000; 14: 2903-2911.
27. Iloh KK, Iloh ON, Ikefuna AN, Ibeziako NS, Ubesie AC, Emodi IJ. Determinants of mother-To-child transmission of HIV despite PMTCT interventions in Enugu, Nigeria. SAJCH 2015; 9: 49-52.
28. Italian Collaborative Study. Mother-To-child transmission of human immunodeficiency virus in Italy: temporal trends and determinants of infection. The Italian Collaborative Study on HIV infection in pregnancy. Human Reprod 1999; 14: 242-246.
29. Italian Register for, HIV, Infection in Children. Determinants of mother-To-infant human immunodeficiency virus 1 transmission before and after the introduction of zidovudine prophylaxis. Arch Pediatr Adolesc Med 2002; 156: 915-921.
30. Kind C, Nadal D, Wyler CA, Siegrist CA, Cheseaux JJ, Vaudaux B, et al. Mother-To-child transmission of human immunodeficiency virus type 1: influence of parity and mode of delivery. Eur J Pediatr 1995; 154: 542-545.
31. Kind C, Rudin C, Siegrist CA, Wyler CA, Biedermann K, Lauper U, et al. Prevention of vertical HIV transmission: additive protective effect of elective cesarean section and zidovudine prophylaxis. AIDS 1998; 12: 205-210.
32. Kreitchmann R, Cohen RA, Stoszek SK, Pinto JA, Losso M, Pierre R, et al. Mode of delivery and neonatal respiratory morbidity among HIV-exposed newborns in Latin America and the Caribbean: NISDI Perinatal-LILAC Studies. Int J Gynaecol Obstet 2011; 114: 91-96.
33. Livingston EG, Huo Y, Patel K, Brogly SB, Tuomala R, Scott GB, et al. Mode of delivery and infant respiratory morbidity among infants born to HIV-1-infected women. Obstet Gynecol 2010; 116 (2 Pt 1): 335-343.
34. Mandelbrot L, Jasseron C, Sibiude J, Azria E, Pannier E, Dommergues M, et al. Cesarean section for HIV-infected women in the era of antiretroviral therapy: clinical practice and mother-To-child transmission in France, 2005-2010. Am J Obstet Gynecol 2013; 208: S310.
35. Mandelbrot L, Le Chenadec J, Berrebi A, Bongain A, Benifla JL, Delfraissy JF, et al. Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA 1998; 280: 55-60.
36. Marcollet A, Goffinet F, Firtion G, Pannier E, Le Bret T, Brival ML, et al. Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery. Am J Obstet Gynecol 2002; 186: 784-789.
37. Mukherjee K. Cost-effectiveness of childbirth strategies for prevention of mother-To-child transmission of HIV among mothers receiving nevirapine in India. Indian J Community Med 2010; 35: 29-33.
38. Navas-Nacher EL, Read JS, Leighty RM, Tuomala RE, Zorrilla CD, Landesman S, et al. Mode of delivery and postpartum HIV-1 disease progression: the Women and Infants Transmission Study. AIDS 2006; 20: 429-436.
39. Newell ML. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994; 343: 1464-1467.
40. Newell ML, Dunn DT, Peckham CS, Semprini AE, Pardi G. Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 1996; 10: 1675-1681.
41. Read JS, Tuomala R, Kpamegan E, Zorrilla C, Landesman S, Brown G, et al. Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study. J Acquir Immune Defic Syndr 2001; 26: 236-245.
42. Ricci E, Parazzini F, Pardi G. Caesarean section and antiretroviral treatment. Italian trial on mode of delivery in HIVpositive women study group. Lancet 2000; 355: 496.
43. Shah I. Is elective caesarian section really essential for prevention of mother to child transmission of HIV in the era of antiretroviral therapy and abstinence of breast feeding?. J Trop Pediatr 2006; 52: 163-165.
44. Succi RCM. Mother-To-child transmission of HIV in Brazil during the years 2000 and 2001: results of a multicentric study. Cadernos de Saude Publica 2007; 23 (Suppl 3): S379-S389.
45. Thorne C, Newell ML. Are girls more at risk of intrauterineacquired HIV infection than boys?. AIDS 2004; 18: 344-347.
46. Tibaldi C, Bucceri A, Perrini G, Rossi G, Ponti A, D'Ambrosio R. Perinatal transmission of HIV virus: risk factors. Italian J Gynaecol Obstet 1994; 6: 44-47.
47. Townsend CL, Byrne L, Cortina-Borja M, Thorne C, de Ruiter A, Lyall H, et al. Earlier initiation of ART and further decline in mother-To-child HIV transmission rates, 2000-2011. AIDS 2014; 28: 1049-1057.
48. Unger JA, Richardson BA, Otieno PA, Farquhar C, Wamalwa D, John-Stewart GC. Mode of delivery and postpartum HIV-1 disease progression and mortality in a Kenyan cohort. BMC Pregnancy Childbirth 2014; 14: 257.
49. Watts DH, Lambert JS, Stiehm ER, Bethel J, Whitehouse J, Fowler MG, et al. Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of or U 500 per microliter. Am J Obstet Gynecol 2000; 183: 100-107.
50. Aebi-Popp K, Mulcahy F, Rudin C, Hoesli I, Gingelmaier A, Lyons F, et al. National Guidelines for the prevention of mother-To-child transmission of HIV across Europe: how do countries differ?. Eur J Public Health 2013; 23: 1053-1058.
51. ACOG Committee on Obstetric Practice. Committee opinion no. 234, scheduled cesarean delivery and the prevention of vertical transmission of HIV infection (Reaffirmed 2015). Obstetrics and gynecology. Washington DC: The American College of Obstetricians and Gynecologists; May 2000. Available from: http://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Schedu led-Cesarean-Delivery-And-The-Prevention-of-Vertical-Transmis sion-of-HIV-Infection. [Accessed 24 April 2017]
52. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Washington DC: National Institutes of Health; 2015. Available from: http://aidsinfo.nih. gov/contentfiles/lvguidelines/PerinatalGL.pdf. [Accessed 24 April 2017]
53. British HIV Association (BHIVA) Writing Group. British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review). HIV Med 2014; 15 (Suppl 4): 1-77.
54. World Health Organization. The prevention and elimination of disrespect and abuse during facility-based childbirth. Geneva, Switzerland: WHO; 2015. Available from: http://apps.who.int/iris/bitstream/10665/134588/1/WHO-RHR-14.23-eng.pdf?ua=1&ua=1. [Accessed 24 April 2017]